Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2634-2643

  Durán Prado, Mario ^a   Gahete, Manuel D ^a   Martínez Fuentes, Antonio J ^a   Luque, Raúl M ^a   Quintero, Ana ^a   Webb, Susan M ^b   Benito López, Pedro ^c   Leal, Alfonso ^d   Schulz, Stefan ^e   Gracia Navarro, F ^a   Malagón, María M ^a   Castaño, Justo P ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COMPLEMENTARY DNA; CORTISTATIN; ISOPROTEIN; MEMBRANE PROTEIN; RNA; SOMATOSTATIN RECEPTOR 5;

ACTH SECRETING ADENOMA; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL LINE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC TRANSFECTION; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

SUIDAE;

EID: 67650245551     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2564     Document Type: Article

References (37)

1. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C 2003 Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2:999-1017
2. Moller LN, Stidsen CE, Hartmann B, Holst JJ 2003 Somatostatin receptors. Biochim Biophys Acta 1616:1-84
3. Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W 2004 Regulation and function of somatostatin receptors. J Neurochem 89:1057-1091
4. Patel YC, Greenwood M, Panetta R, Hukovic N, Grigorakis S, Robertson LA, Srikant CB 1996 Molecular biology of somatostatin receptor subtypes. Metabolism 45:31-38
5. Reisine T, Kong H, Raynor K, Yano H, Takeda J, Yasuda K, Bell GI 1993 Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase. Mol Pharmacol 44:1016-1020
6. Vanetti M, Kouba M, Wang X, Vogt G, Hollt V 1992 Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett 311:290-294
7. de Lecea L, Castano JP 2006 Cortistatin: not just another somatostatin analog. Nat Clin Pract Endocrinol Metab 2:356-357
8. Volante M, Rosas R, Allia E, Granata R, Baragli A, Muccioli G, Papotti M 2008 Somatostatin, cortistatin and their receptors in tumours. Mol Cell Endocrinol 286:219-229
9. Gahete MD, Duran-Prado M, Luque RM, Martinez-Fuentes AJ, Vazquez-Martinez R, Malagon MM, Castano JP 2008 Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead. Mol Cell Endocrinol 286:128-134
10. Gonzalez-Rey E, Chorny A, Del Moral RG, Varela N, Delgado M 2007 Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses. Ann Rheum Dis 66:582-588
11. Gonzalez-Rey E, Delgado M 2007 Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders. Mol Cell Endocrinol 286:135-140
12. Jaquet P, Saveanu A, Barlier A 2005 New SRIF analogs in the control of human pituitary adenomas: perspectives. J Endocrinol Invest 28:14-18
13. Taboada GF, Luque RM, Bastos W, Guimaraes RF, Marcondes JB, Chimelli LM, Fontes R, Mata PJ, Filho PN, Carvalho DP, Kineman RD, Gadelha MR 2007 Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas. Eur J Endocrinol 156:65-74
14. Tallent M, Dichter MA, Reisine T 1996 Evidence that a novel somatostatin receptor couples to an inward rectifier potassium current in AtT-20 cells. Neuroscience 73:855-864
15. Chanson P, Timsit J, Harris AG 1993 Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours. Clin Pharmacokinet 25:375-391
16. Jones RH, Reubi JC, Millan D, Vasey P 2004 Octreotide: an active agent in epithelial ovarian carcinoma? Lancet Oncol 5:251-253
17. Saveanu A, Gunz G, Dufour H, Caron P, Fina F, Ouafik L, Culler MD, Moreau JP, Enjalbert A, Jaquet P 2001 Bim-23244, a somatostatin receptor subtype 2-and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. J Clin Endocrinol Metab 86:140-145
18. Kilpatrick GJ, Dautzenberg FM, Martin GR, Eglen RM 1999 7TM receptors: the splicing on the cake. Trends Pharmacol Sci 20:294-301
19. Havt A, Schally AV, Halmos G, Varga JL, Toller GL, Horvath JE, Szepeshazi K, Koster F, Kovitz K, Groot K, Zarandi M, Kanashiro CA 2005 The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci USA 102:17424-17429
20. Rekasi Z, Czompoly T, Schally AV, Halmos G 2000 Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc Natl Acad Sci USA 97:10561-10566
21. Hawrylyshyn KA, Michelotti GA, Coge F, Guenin SP, Schwinn DA 2004 Update on human α1-adrenoceptor subtype signaling and genomic organization. Trends Pharmacol Sci 25:449-455
22. McWilliams DF, Watson SA, Crosbee DM, Michaeli D, Seth R 1998 Coexpression of gastrin and gastrin receptors (CCK-B and ΔCCK-B) in gastrointestinal tumour cell lines. Gut 42:795-798
23. Patel YC, Panetta R, Escher E, Greenwood M, Srikant CB 1994 Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem 269:1506-1509
24. Luque RM, Duran-Prado M, Garcia-Navarro S, Gracia-Navarro F, Kineman RD, Malagon MM, Castano JP 2006 Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion. Endocrinology 147:2902-2908
25. Duran-Prado M, Bucharles C, Gonzalez BJ, Vazquez-Martinez R, Martinez-Fuentes AJ, Garcia-Navarro S, Rhodes SJ, Vaudry H, Malagon MM, Castano JP 2007 Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization. Endocrinology 148:411-421
26. Van Zeveren AM, Visser A, Hoorens PR, Vercruysse J, Claerebout E, Geldhof P 2007 Evaluation of reference genes for quantitative real-time PCR in Ostertagia ostertagi by the coefficient of variation and geNorm approach. Mol Biochem Parasitol 153:224-227
27. Burstein ES, Spalding TA, Brann MR 1998 The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling. J Biol Chem 273:24322-24327
28. Gether U 2000 Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90-113
29. Siehler S 2008 Cell-based assays in GPCR drug discovery. Biotechnol J 3:471-483
30. Takahashi K, Furukawa C, Takano A, Ishikawa N, Kato T, Hayama S, Suzuki C, Yasui W, Inai K, Sone S, Ito T, Nishimura H, Tsuchiya E, Nakamura Y, Daigo Y 2006 The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res 66:9408-9419
31. Papotti M, Bongiovanni M, Volante M, Allia E, Landolfi S, Helboe L, Schindler M, Cole SL, Bussolati G 2002 Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch 440:461-475
32. Notas G, Kolios G, Mastrodimou N, Kampa M, Vasilaki A, Xidakis C, Castanas E, Thermos K, Kouroumalis E 2004 Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors. J Hepatol 40:792-798
33. Reubi JC, Waser B, Liu Q, Laissue JA, Schonbrunn A 2000 Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location. J Clin Endocrinol Metab 85:3882-3891
34. Stroh T, Sarret P, Tannenbaum GS, Beaudet A 2006 Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus. Neurochem Res 31:247-257
35. Seck T, Pellegrini M, Florea AM, Grignoux V, Baron R, Mierke DF, Horne WC 2005 The Δe13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling. Mol Endocrinol (Baltimore, Md) 19:2132-2144
36. Spier AD, de Lecea L 2000 Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev 33:228-241
37. Gonzalez-Rey E, Chorny A, Robledo G, Delgado M 2006 Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med 203:563-571